A Study of Pitolisant in Patients with Prader-Willi Syndrome
- Conditions
- Interventions
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 134
- Registration Number
- NCT06366464
- Locations
- ๐บ๐ธ
Santa Monica Clinical Trials, Los Angeles, California, United States
๐บ๐ธRady Children's Hospital - Scan Diego, San Diego, California, United States
๐บ๐ธCenter of Excellence in Diabetes and Endocrinology, Sacramento, California, United States
WAKIXยฎ (Pitolisant) Pregnancy Registry
- Conditions
- Interventions
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 1329
- Registration Number
- NCT05536011
- Locations
- ๐บ๐ธ
Evidera (PPD), Morrisville, North Carolina, United States
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
- Conditions
- Interventions
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 128
- Registration Number
- NCT05458128
- Locations
- ๐บ๐ธ
Clinical Neurophysiology Services, Sterling Heights, Michigan, United States
๐บ๐ธWestern Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, United States
๐บ๐ธSleep Dynamics, Neptune City, New Jersey, United States
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
- Conditions
- Interventions
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 214
- Registration Number
- NCT05156047
- Locations
- ๐บ๐ธ
Santa Monica Clinical Trials, Santa Monica, California, United States
๐บ๐ธLowcountry Lung Critical Care, North Charleston, South Carolina, United States
๐บ๐ธNorthShore Uni HealthSys-Glenbrook Hospital, Glenview, Illinois, United States
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
- Conditions
- Interventions
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT04886518
- Locations
- ๐จ๐ฆ
Hรดpital de Chicoutimi, Chicoutimi, Quebec, Canada
๐จ๐ฆThe Ottawa Hospital, Ottawa, Ontario, Canada
๐บ๐ธUCI Center for Clinical Research, Irvine, California, United States
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
- Conditions
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 65
- Registration Number
- NCT04257929
- Locations
- ๐บ๐ธ
CTI, Cincinnati, Ohio, United States
๐บ๐ธUniversity of Nebraska Medical Center, Omaha, Nebraska, United States
๐บ๐ธVanderbilt University Medical Center, Nashville, Tennessee, United States
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Harmony Biosciences, LLC
- Registration Number
- NCT03433131
- Locations
- ๐บ๐ธ
St. Lukes Hospital, Sleep Medicine, Chesterfield, Missouri, United States
๐บ๐ธEmory University, Atlanta, Georgia, United States
๐บ๐ธNorthwestern Medical Group, Chicago, Illinois, United States